| Literature DB >> 32410446 |
Angeliki Moutsiopoulou1,2, David Broyles1, Hamdi Joda1, Emre Dikici1, Avinash Kaur1, Angel Kaifer2, Sylvia Daunert1,3,4, Sapna K Deo1,3.
Abstract
Although bioluminescent molecular beacons designed around resonance quenchers have shown higher signal-to-noise ratios and increased sensitivity compared with fluorescent beacon systems, bioluminescence quenching is still comparatively inefficient. A more elegant solution to inefficient quenching can be realized by designing a competitive inhibitor that is structurally very similar to the native substrate, resulting in essentially complete substrate exclusion. In this work, we designed a conjugated anti-interferon-γ (IFN-γ) molecular aptamer beacon (MAB) attached to a bioluminescent protein, Gaussia luciferase (GLuc), and an inhibitor molecule with a similar structure to the native substrate coelenterazine. To prove that a MAB can be more sensitive and have a better signal-to-noise ratio, a bioluminescence-based assay was developed against IFN-γ and provided an optimized, physiologically relevant detection limit of 1.0 nM. We believe that this inhibitor approach may provide a simple alternative strategy to standard resonance quenching in the development of high-performance molecular beacon-based biosensing systems.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32410446 PMCID: PMC7955708 DOI: 10.1021/acs.analchem.0c00518
Source DB: PubMed Journal: Anal Chem ISSN: 0003-2700 Impact factor: 6.986